Literature DB >> 31626926

Outcomes following Lower Extremity Amputation in Patients with Diabetes Mellitus and Peripheral Arterial Disease.

Poya Pourghaderi1, Kyle M Yuquimpo2, Camila Roginski Guetter3, Lauren Mansfield4, Henry Soo-Min Park5.   

Abstract

BACKGROUND: Lower extremity amputations (LEAs) are projected to increase drastically in the United States. The potential effects of diabetes mellitus (DM) and peripheral arterial disease (PAD) on LEA outcomes have not been well-explored. We sought to investigate the clinical outcomes of LEA in patients with DM alone, PAD alone, and patients with concurrent DM and PAD (DM + PAD) from the Healthcare Cost and Utilization Project Nationwide Inpatient Sample.
METHODS: Adult patients (≥18 years) undergoing LEA in 2007-2011 based on ICD-9 procedure codes were selected. Patient morbidity, and mortality were assessed utilizing logistic and linear regression. Multivariable analyses adjusted for additional patient and hospital characteristics.
RESULTS: A total of 62,291 LEAs were identified between 2007 and 2011. The mean (SD) age was 66.4 (13.7) years. Patients were predominantly Caucasian (56.4%), male (62.9%), and admitted as an emergency admission (44.1%). A higher incidence of LEA was observed in patients with DM + PAD (47.3%) than those with either DM alone (26.4%) or PAD alone (26.3%). On adjustment for patient characteristics, PAD alone was associated with significantly higher mortality and complications postoperatively (OR 1.71; P < 0.001, and 1.28; P < 0.001, respectively), but concurrent DM + PAD was not associated with these outcomes.
CONCLUSION: Outcomes were significantly affected by presence of PAD as a comorbidity in patients undergoing LEA. It is imperative to understand and enhance preventive measures and screening guidelines for such comorbidities to optimize postoperative outcomes to ensure best-practice care in this patient population.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31626926     DOI: 10.1016/j.avsg.2019.08.084

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  Modernizing Diabetes Care Quality Measures.

Authors:  David H Jiang; Patrick J O'Connor; Nathalie Huguet; Sherita Hill Golden; Rozalina G McCoy
Journal:  Health Aff (Millwood)       Date:  2022-06-27       Impact factor: 9.048

2.  Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease.

Authors:  Yun Shen; Dongjun Dai; Jingyi Lu; Yufei Wang; Wei Zhu; Yuqian Bao; Gang Hu; Jian Zhou
Journal:  Cardiovasc Diabetol       Date:  2020-12-10       Impact factor: 9.951

3.  Serum Legumain Is Associated with Peripheral Artery Disease in Patients with Type 2 Diabetes.

Authors:  Wen Wei; Shujin Chen; Jianqing Huang; Yan Tong; Jushun Zhang; Xiuping Qiu; Wenrui Zhang; Hangju Chen; Rong Huang; Jin Cai; Mei Tu
Journal:  J Diabetes Res       Date:  2021-12-18       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.